Michael Moynihan
Technik-/Wissenschafts-/F&E-Leiter bei 22nd Century Ltd. LLC
Profil
Michael Robert Moynihan currently works at 22nd Century Ltd.
LLC, as Vice President-Research & Development from 2007.
Dr. Moynihan also formerly worked at Fundación Chile, as Director-Biotechnology Development in 2006, InterLink Biotechnologies LLC, as Senior Project Director in 2000, and 22nd Century Group, Inc., as Vice President-Research & Development from 2011 to 2017.
Dr. Moynihan received his undergraduate degree from Brown University and graduate degree and doctorate degree from Harvard University.
Aktive Positionen von Michael Moynihan
| Unternehmen | Position | Beginn |
|---|---|---|
22nd Century Ltd. LLC
 22nd Century Ltd. LLC Agricultural Commodities/MillingProcess Industries 22nd Century Ltd. LLC operates as a plant biotechnology company. It provides plant cultivation services for the tobacco industry. The firm’s proprietary technology allows for the level of nicotine and other nicotinic alkaloids in the tobacco plant to be decreased or increased through genetic engineering and breeding. The company was founded by Joseph Pandolfino in 1998 and is headquartered in Williamsville, NY. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
Ehemalige bekannte Positionen von Michael Moynihan
| Unternehmen | Position | Ende |
|---|---|---|
| 22ND CENTURY GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2017 |
Fundación Chile
 Fundación Chile Miscellaneous Commercial ServicesCommercial Services Fundación Chile is a non profit corporation. The company provides business incubation services to start-up companies in the biotechnology, aquaculture, and food industries. It engages in consultancy, training, and advisory programs, as well as research, technical support, and software design. The company was founded in 1976, and is headquartered in Santiago, Chile. | Corporate Officer/Principal | 01.01.2006 |
InterLink Biotechnologies LLC
 InterLink Biotechnologies LLC Pharmaceuticals: MajorHealth Technology InterLink Biotechnologies LLC develops drug discovery platform of novel natural products derived from microorganisms. Its products include new pharmaceutical drugs, antimicrobial peptides, enzymes as additives for human food and animal feed products, and bio-control agents. The company was founded by Ramon L. Garcia-Lazcano in 1991 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Michael Moynihan
| Brown University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 22ND CENTURY GROUP, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
22nd Century Ltd. LLC
22nd Century Ltd. LLC Agricultural Commodities/MillingProcess Industries 22nd Century Ltd. LLC operates as a plant biotechnology company. It provides plant cultivation services for the tobacco industry. The firm’s proprietary technology allows for the level of nicotine and other nicotinic alkaloids in the tobacco plant to be decreased or increased through genetic engineering and breeding. The company was founded by Joseph Pandolfino in 1998 and is headquartered in Williamsville, NY. | Process Industries |
Fundación Chile
Fundación Chile Miscellaneous Commercial ServicesCommercial Services Fundación Chile is a non profit corporation. The company provides business incubation services to start-up companies in the biotechnology, aquaculture, and food industries. It engages in consultancy, training, and advisory programs, as well as research, technical support, and software design. The company was founded in 1976, and is headquartered in Santiago, Chile. | Commercial Services |
InterLink Biotechnologies LLC
InterLink Biotechnologies LLC Pharmaceuticals: MajorHealth Technology InterLink Biotechnologies LLC develops drug discovery platform of novel natural products derived from microorganisms. Its products include new pharmaceutical drugs, antimicrobial peptides, enzymes as additives for human food and animal feed products, and bio-control agents. The company was founded by Ramon L. Garcia-Lazcano in 1991 and is headquartered in Princeton, NJ. | Health Technology |